Edition:
United States

Abbott Laboratories (ABT.N)

ABT.N on New York Stock Exchange

52.51USD
22 Sep 2017
Change (% chg)

$1.08 (+2.10%)
Prev Close
$51.43
Open
$51.51
Day's High
$52.58
Day's Low
$51.51
Volume
2,323,273
Avg. Vol
1,711,825
52-wk High
$52.60
52-wk Low
$37.38

Summary

Name Age Since Current Position

Miles White

62 1999 Chairman of the Board, Chief Executive Officer

Brian Yoor

47 2015 Chief Financial Officer, Senior Vice President - Finance

Michael Rousseau

61 2017 President - Cardiovascular and Neuromodulation

Hubert Allen

51 2013 Executive Vice President, General Counsel, Secretary

Stephen Fussell

59 2013 Executive Vice President - Human Resources

Brian Blaser

52 2012 Executive Vice President - Diagnostics Products

John Capek

55 2015 Executive Vice President - Ventures

Robert Ford

43 2015 Executive Vice President - Medical Devices

Heather Mason

56 2015 Executive Vice President - Nutritional Products

Roger Bird

60 2015 Senior Vice President - U.S. Nutrition

Jaime Contreras

60 2013 Senior Vice President - Core Laboratory Diagnostics, Commercial Operations

Eric Fain

56 2017 Senior Vice President, Group President - Cardiovascular and Neuromodulation

Thomas Frinzi

61 2016 Senior Vice President - Abbott Medical Optics

Andrew Lane

46 2015 Senior Vice President - Established Pharmaceuticals, Emerging Markets

Joseph Manning

48 2017 Senior Vice President - Abbott Nutrition International

Deepak Nath

44 2015 Senior Vice President - Abbott Vascular

Daniel Salvadori

38 2014 Senior Vice President - Established Pharmaceuticals, Latin America.

Jared Watkin

49 2015 Senior Vice President - Diabetes Care

Robert Funck

55 2013 Vice President, Controller

William Osborn

69 2013 Lead Independent Director

John Stratton

2017 Director

Robert Alpern

66 2008 Independent Director

Roxanne Austin

56 2000 Independent Director

Sally Blount

55 2011 Independent Director

Edward Liddy

71 2010 Independent Director

Nancy McKinstry

58 2011 Independent Director

Phebe Novakovic

59 2010 Independent Director

Samuel Scott

72 2007 Independent Director

Daniel Starks

62 2017 Independent Director

Glenn Tilton

68 2007 Independent Director

Biographies

Name Description

Miles White

Mr. Miles D. White serves as Chairman of the Board, Chief Executive Officer of the Company. Mr. White served as an Executive Vice President of Abbott from 1998 to 1999. He joined Abbott in 1984. He currently serves as a Director of Caterpillar Inc. and McDonald's Corporation. Serving as Abbott's Chairman of the Board and Chief Executive Officer since 1999 and having joined Abbott in 1984, Mr. White contributes not only his valuable business, management and leadership experience, but also his extensive knowledge of the Company and its global operations, as well as key insights into strategic, management and operation matters, ensuring the appropriate level of oversight and responsibility is applied to all Board decisions.

Brian Yoor

Mr. Brian B. Yoor serves as Chief Financial Officer, Senior Vice President - Finance of the Company. He has served as the Company’s Vice President, Investor Relations since 2013, and as Divisional Vice President, Controller Diagnostic Products from 2010 to 2013. Mr. Yoor became a corporate officer in 2013.

Michael Rousseau

Mr. Michael T. Rousseau is President - Cardiovascular and Neuromodulation of the Company. From 2016 to 2017 — President and Chief Executive Officer, St. Jude Medical, Inc. (a global medical device manufacturer). And also 2014 to 2015 — Chief Operating Officer, St. Jude Medical, Inc. He was from 2012 to 2014 — Group President, Cardiovascular and Ablation Technologies Division, Implantable Electronic Systems Division and U.S. Division, St. Jude Medical, Inc. He was 2009 to 2012 — Group President, Cardiac Rhythm Management Division, Neuromodulation Division, Atrial Fibrillation Division, Cardiovascular Division and U.S. Division, St. Jude Medical, Inc.

Hubert Allen

Mr. Hubert L. Allen is Executive Vice President, General Counsel and Secretary of the Company. From 2010 to 2012 — Divisional Vice President and Associate General Counsel, Established Pharmaceuticals; 2009 to 2010 — Divisional Vice President and Associate General Counsel, Proprietary Pharmaceuticals; 2007 to 2009 — Section Head, Legal, Abbott Nutrition. He is Elected Corporate Officer in 2012

Stephen Fussell

Mr. Stephen R. Fussell is Executive Vice President - Human Resources of Abbott Laboratories. Previously, he served as Vice President, Compensation and Development. Mr. Fussell joined Abbott in 1996, as Divisional Vice President, Compensation and Benefits. Prior to joining Abbott, Mr. Fussell was Vice President, Total Compensation and Workforce Information at Nestlé USA. Mr. Fussell is a board member for the Clara Abbott Foundation and the Abbott Fund. He earned a Bachelor's degree in Management and Administration from Louisiana State University in Baton Rouge.

Brian Blaser

Mr. Brian J. Blaser serves as Executive Vice President - Diagnostics Products of the Company. Mr. Blaser was appointed to his current position in June 2010. Previously, Mr. Blaser served as Vice President, Diagnostics Operations; Divisional Vice President, Global Operations; and Divisional Vice President, Reagent Manufacturing, all for Abbott Diagnostics. Prior to joining Abbott, Mr. Blaser held several positions of increasing responsibility in engineering, finance and operations at Johnson & Johnson, Eastman Kodak and General Motors. He earned a bachelor's degree in mechanical engineering technology from the University of Dayton and a master's degree in business administration from Rochester Institute of Technology.

John Capek

Dr. John M. Capek, Ph.D. is Executive Vice President - Ventures of the Company. Previously, he served as Senior Vice President, Abbott Vascular, heading up Abbott's global vascular business. Dr. Capek served in various management roles at Guidant, including president, Guidant Vascular Intervention and Vice President and General Manager of Bioabsorbable Vascular Solutions. He also served as Vice President and General Manager of Guidant Germany and Vice President, Marketing, Guidant Cardiac Rhythm Management Group. Before joining Guidant, Dr. Capek was manager of New Product Technology at Eli Lilly & Company. Dr. Capek has a Bachelor's degree in Biomedical Engineering, a Master's degree in Biomedical Engineering, a Master's degree in Electrical Engineering, a Ph.D. in Biomedical Engineering and a Master's degree in Business Administration from Rensselaer Polytechnic Institute.

Robert Ford

Mr. Robert B. Ford is Executive Vice President - Medical Devices of the Company. He served as Senior Vice President, Diabetes Care of the Company between 2014 and 2015. From 2008 to 2014 — Vice President, Diabetes Care, Commercial Operations. He was elected Corporate Officer — 2008.

Heather Mason

Ms. Heather L. Mason is Executive Vice President - Nutritional Products of the Company. Ms. Mason served as Executive Vice President - Nutritional Products, Global Commercial Operations.of the company fro 2014-2015. Ms. Mason previously served as Vice President, Latin American Operations in Abbott's international pharmaceutical business. Ms. Mason joined Abbott in 1990. She held a number of positions in Abbott's U.S. pharmaceutical business, including oversight of Abbott's specialty pharmaceuticals, the diabetes/metabolics and oncology franchises, and managed health care. Ms. Mason also served as Vice President, International Marketing in Abbott's international pharmaceutical business. Prior to joining Abbott, Ms. Mason worked for Quaker Oats and FMC Corporation. Ms. Mason is an advisory board member of the Healthcare Businesswomen’s Association and Corporate Advisor for the Juvenile Diabetes Research Foundation and American Diabetes Association. She earned a Bachelor's degree in Engineering from the University of Michigan and a Master's degree in Business Administration from the University of Chicago.

Roger Bird

Mr. Roger Bird is Senior Vice President - U.S. Nutrition of the Company. Between 2009 to 2015 he is Divisional Vice President and General Manager, China and Hong Kong, Nutritional Products. He is Elected Corporate Officer 2015.

Jaime Contreras

Mr. Jaime Contreras is the Senior Vice President - Core Laboratory Diagnostics, Commercial Operations of Abbott Laboratories. From 2008 to 2013 he was Vice President, Diagnostics, Global Commercial Operations.

Eric Fain

Dr. Eric S. Fain, M.D., is Senior Vice President, Group President - Cardiovascular and Neuromodulation of the Company. From 2014 to 2017 — Group President, St. Jude Medical, Inc. (a global medical device manufacturer). And He was from 2012 to 2014 — President, Implantable Electronic Systems Division, St. Jude Medical, Inc. From 2012 to 2014 — Group President, Cardiovascular and Ablation Technologies Division, Implantable Electronic Systems Division and U.S. Division, St. Jude Medical, Inc. From 2007 to 2012 — President, Cardiac Rhythm Management Division, St. Jude Medical, Inc.

Thomas Frinzi

Mr. Thomas G. Frinzi is Senior Vice President - Abbott Medical Optics of the Company. From 2010 to 2015 he is President and Chief Executive Officer, WaveTec Vision Systems, Inc. (a leading U.S. developer of guidance technology for cataract surgery).

Andrew Lane

Mr. Andrew H. Lane is Senior Vice President - Established Pharmaceuticals, Emerging Markets of the Company. From 2014 to 2015 served with Divisional Vice President, Established Pharmaceuticals, Asia Pacific. Between 2011 to 2014 Lane is Vice President, Asia Pacific, Takeda Pharmaceutical Company Limited (a Japanese pharmaceutical company).

Joseph Manning

Mr. Joseph Manning is Senior Vice President - Abbott Nutrition International of the Company. From 2015 to 2017 he was Vice President, Nutrition, Asia Pacific. From 2014 to 2015 he was General Manager, Indonesia, Nutritional Products. From 2009 to 2014 he was General Manager, Russia, Nutritional Products.

Deepak Nath

Mr. Deepak S. Nath is Senior Vice President - Abbott Vascular of the Company. Currently he is Vice President, Vascular, Commercial. Between 2014 to 2015 he is Vice President, Molecular Diagnostics. Between 2012 to 2014 he is Divisional Vice President and General Manager, Ibis. Between 2011 to 2012 he is Divisional Vice President, CEEMEA, Vascular. Between 2009 to 2011 he is Divisional Vice President and General Manager, Nordics and Eastern European Operations, Vascular.

Daniel Salvadori

Mr. Daniel Gesua Sive Salvadori is Senior Vice President - Established Pharmaceuticals, Latin America of the Company. From 2013 to 2014 — Chief Executive Officer, Latin America, CFR Pharmaceuticals S.A. (a Latin American pharmaceutical company). From 2012 to 2013 — Executive President, Complex Therapeutics Division, CFR Pharmaceuticals S.A. From 2010 to 2012 — Head of Sales and Marketing, Latin America, Sandoz Pharmaceuticals, Novartis AG (a Swiss multinational pharmaceutical company). From 2009 to 2010 — Director of Global Strategy and Mergers and Acquisitions, Sandoz Pharmaceuticals, Novartis AG.

Jared Watkin

Mr. Jared L. Watkin is Senior Vice President - Diabetes Care of the Company. Between 2010 to 2015 Divisional Vice President, Technical Operations, Diabetes Care. Elected as Corporate Officer in 2015.

Robert Funck

Mr. Robert E. Funck is Vice President, Controller of Abbott Laboratories. Mr. Funck has served as the Company’s Vice President, Chief Ethics and Compliance Officer since 2009, as Vice President, Internal Audit from 2007 to 2009, and as Vice President and Treasurer from 2005 to 2007.

William Osborn

Mr. William A. Osborn serves as Lead Independent Director of the Company. Mr. Osborn was Chairman of Northern Trust Corporation from 1995 through 2009 and served as its Chief Executive Officer from 1995 through 2007. Mr. Osborn currently serves as a Director of Caterpillar Inc. and General Dynamics Corporation. He is Chairman of the Board of Trustees of Northwestern University. Mr. Osborn served on the Board of Directors of Nicor, Inc. from 1999 to 2006 and on the Board of Directors of Tribune Company from 2001 to 2012. As the Chairman and Chief Executive Officer of Northern Trust Corporation and The Northern Trust Company,

John Stratton

Robert Alpern

Dr. Robert J. Alpern, M.D. , serves as Independent Director of the Company. Dr. Alpern has served as the Ensign Professor of Medicine, Professor of Internal Medicine, and Dean of Yale School of Medicine since June 2004. From July 1998 to June 2004, Dr. Alpern was the Dean of The University of Texas Southwestern Medical Center. Dr. Alpern also serves as a Director of AbbVie Inc. and as a Director on the Board of Yale—New Haven Hospital. As the Ensign Professor of Medicine, Professor of Internal Medicine, and Dean of Yale School of Medicine, Dean of The University of Texas Southwestern Medical Center, and as a Director on the Board of Yale—New Haven Hospital, Dr. Alpern contributes valuable insights to the Board through his medical and scientific expertise and his knowledge of the health care environment and the scientific nature of Abbott's key research and development initiatives.

Roxanne Austin

Ms. Roxanne S. Austin serves as Independent Director of the Company. Ms. Austin is President and Chief Executive Officer of Austin Investment Advisors, a private investment and consulting firm, a position she has held since 2004. From July 2009 through July 2010, Ms. Austin also served as the President and Chief Executive Officer of Move Networks, Inc., a provider of Internet television services. Ms. Austin served as President and Chief Operating Officer of DIRECTV, Inc. Ms. Austin also previously served as Executive Vice President and Chief Financial Officer of Hughes Electronics Corporation and as a partner of Deloitte & Touche LLP. Ms. Austin served on the Board of Directors of Telefonaktiebolaget LM Ericsson from 2008 to 2016. Ms. Austin currently serves on the Board of Directors of AbbVie Inc., Target Corporation, and Teledyne Technologies, Inc.

Sally Blount

Ms. Sally E. Blount, Ph.D., serves as Independent Director of the Company. Ms. Blount has served as Dean of the J.L. Kellogg Graduate School of Management and the Michael L. Nemmers Professor of Management and Organizations at Northwestern University since July 2010. From 2004 to 2010, she served as the Vice Dean and Dean of the undergraduate college of New York University's Leonard N. Stern School of Business. Ms. Blount joined the faculty of New York University's Leonard N. Stern School of Business in 2001 and was the Abraham L. Gitlow Professor of Management and Organizations. Prior to joining NYU in 2001, Ms. Blount held academic posts at the University of Chicago's Graduate School of Business from 1992 to 2001. As Dean of the J.L. Kellogg Graduate School of Management at Northwestern University and as the Vice Dean and Dean of the undergraduate college of New York University's Leonard N. Stern School of Business,

Edward Liddy

Mr. Edward M. Liddy serves as Independent Director of the Company. Mr. Liddy served as a partner in the private equity investment firm Clayton, Dubilier & Rice, LLC from January 2010 to December 2015. At the request of the Secretary of the U.S. Department of Treasury, Mr. Liddy served as Interim Chairman and Chief Executive Officer of American International Group, Inc., a global insurance and financial services holding company, from September 2008 until August 2009. From January 1999 to April 2008, Mr. Liddy served as Chairman of the Board of the Allstate Corporation. He served as Chief Executive Officer of Allstate from January 1999 to December 2006, President from January 1995 to May 2005, and Chief Operating Officer from August 1994 to January 1999. Mr. Liddy currently serves on the Board of Directors of AbbVie Inc., 3M Company, and The Boeing Company. Through his executive leadership at Allstate and American International Group, and his board service at several Fortune 100 companies across a broad range of industries, Mr. Liddy provides valuable insights on corporate strategy, risk management, corporate governance and many other issues facing large, global enterprises. Additionally, as a former chief financial officer, audit committee chair at Goldman Sachs and 3M Company, and partner at Clayton, Dubilier & Rice, LLC, Mr. Liddy provides significant knowledge and understanding of corporate finance, capital markets, financial reports and accounting matters.

Nancy McKinstry

Ms. Nancy McKinstry serves as Independent Director of the Company. Ms. McKinstry has been the Chief Executive Officer and Chairman of the Executive Board of Wolters Kluwer N.V. since September 2003 and a member of its Executive Board since June 2001. Ms. McKinstry also serves on the Board of Accenture, the Board of Overseers of Columbia Business School, and the Board of Directors of Russell Reynolds Associates. Ms. McKinstry is also a member of the European Round Table of Industrialists. Ms. McKinstry served on the Board of Directors of Telefonieaktiebolaget LM Ericsson (LM Ericsson Telephone Company) from 2004 to 2012. As the Chief Executive Officer and Chairman of the Executive Board of Wolters Kluwer N.V., Ms. McKinstry contributes global perspectives and management experience, including an understanding of key issues facing a multinational business such as Abbott's.

Phebe Novakovic

Ms. Phebe N. Novakovic serves as Independent Director of the Company. Ms. Novakovic has been Chairman and Chief Executive Officer of General Dynamics Corporation since January 1, 2013. Previously, she served as President and Chief Operating Officer from May 2012 to December 2012 and as Executive Vice President, Marine Systems of General Dynamics from May 2010 to May 2012. From May 2005 to April 2010, Ms. Novakovic served as its Senior Vice President—Planning and Development. She was elected Vice President of General Dynamics in October 2002 after joining the company in May 2001. Previously, Ms. Novakovic was Special Assistant to the Secretary and Deputy Secretary of Defense, and had been a Deputy Associate Director of the Office of Management and Budget.

Samuel Scott

Mr. Samuel C. Scott, III., serves as Independent Director of the Company. Mr. Scott retired as Chairman, President and Chief Executive Officer of Corn Products International in 2009. He served as Chairman, President, and Chief Executive Officer from February 2001 until he retired in May of 2009. He was President and Chief Operating Officer from January 1998 until February 2001. He was President of the Corn Refining Division of CPC International from 1995 through 1997, when CPC International spun off Corn Products International as a separate corporation. Mr. Scott currently serves on the Board of Directors of Bank of New York Mellon Corporation and Motorola Solutions, Inc. As the Chairman, President and Chief Executive Officer of Corn Products International,

Daniel Starks

Mr. Daniel J. Starks serves as Independent Director of the Company. Mr. Starks served as the Chairman, President and Chief Executive Officer of St. Jude Medical, Inc., from 2004 until his retirement in January 2016, after which he served as its Executive Chairman of the Board until January 2017, when Abbott completed the acquisition of St. Jude Medical, Inc. Mr. Starks also served as President and Chief Operating Officer of St. Jude Medical, Inc. from 2001 to 2004 and as its President and CEO, Cardiac Rhythm Management Business from 1997 to 2001.

Glenn Tilton

Mr. Glenn Fletcher Tilton serves as Independent Director of the Company. Mr. Tilton served as Chairman of the Midwest for JPMorgan Chase & Co. and a member of its companywide Executive Committee from June 2011 to June 2014. From October 2010 to December 2012, Mr. Tilton also served as the Non-Executive Chairman of the Board of United Continental Holdings, Inc. From September 2002 to October 2010, he served as Chairman, President and Chief Executive Officer of UAL Corporation, a holding company, and Chairman and Chief Executive Officer of United Air Lines, Inc., an air transportation company and wholly owned subsidiary of UAL Corporation. Mr. Tilton is also a Director of AbbVie Inc. and Phillips 66. Mr. Tilton also served on the Board of Directors of Lincoln National Corporation from 2002 to 2007, of TXU Corporation from 2005 to 2007, of Corning Incorporated from 2010 to 2012, and of United Continental Holdings, Inc. from 2001 to 2013. Having previously served as Chairman of the Midwest for JPMorgan Chase & Co., Non-Executive Chairman of the Board of United Continental Holdings, Inc., Chairman, President, and Chief Executive Officer of UAL Corporation and United Air Lines, Vice Chairman of Chevron Texaco, and as Interim Chairman of Dynegy, Inc.,